Vemurafenib Drives Epithelial-to-Mesenchymal Transition Gene Expression in BRAF Inhibitor‒Resistant BRAFV600E/NRASQ61K Melanoma Enhancing Tumor Growth and Metastasis in a Bioluminescent Murine Model-Reference-Cited by-同舟云学术

Vemurafenib Drives Epithelial-to-Mesenchymal Transition Gene Expression in BRAF Inhibitor‒Resistant BRAFV600E/NRASQ61K Melanoma Enhancing Tumor Growth and Metastasis in a Bioluminescent Murine Model

Published:2021-10 Issue: Volume: Page:
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Jandova Jana^ORCID,Wondrak Georg T.^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference57 articles.

1. Phenotype plasticity as enabler of melanoma progression and therapy resistance;Arozarena;Nat Rev Cancer,2019

2. GLO1 overexpression in human malignant melanoma;Bair;Melanoma Res,2010

3. Progression of RAS-mutant leukemia during RAF inhibitor treatment;Callahan;N Engl J Med,2012

4. Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor;Caporali;Int J Oncol,2016

5. BRAF and NRAS mutations are heterogeneous and not mutually exclusive in nodular melanoma;Chiappetta;Appl Immunohistochem Mol Morphol,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanotransferrin (MELTF, MFI2, CD228) Expression Attenuates Malignant Melanoma Progression in the A375-Luc2 Murine Metastasis Model and Human Patients;Journal of Investigative Dermatology;2024-06

2. Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospective study;Journal of Gastrointestinal Oncology;2024-04

3. Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance;Heliyon;2023-07

4. Systemic deuteration of SCID mice using the water‐isotopologue deuterium oxide (D₂O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma;Molecular Carcinogenesis;2023-02-02

5. Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling;Cancers;2022-12-10